National Cancer Institute (EEUU) y el Gynecologic Oncology Group tambien de EEUU llevan a cabo una Fase II en Ovario con Yondelis + Docetaxel

Docetaxel, Trabectedin, and G-CSF or Pegfilgrastim in Treating Patients With Recurrent or Persistent Ovarian Epithelial Cancer, Primary Peritoneal Cavity Cancer, or Fallopian Tube Cancer .